Cite
HARVARD Citation
Amin, A. et al. (2016). Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States. Clinical and applied thrombosis/hemostasis. pp. 5-11. [Online].